Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13467InvestigationalSmall molecule
Lanatoside C: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on E3 ubiquitin-protein ligase CHIP
- Formula / weight
- C49H76O20 · 985.127 g/mol (avg)
- Code names
- NSC-119991 · NSC-7533
Resolves to
Clinical / RWD
Structure
InChIKey
JAYAGJDXJIDEKI-PTGWOZRBSA-NSMILES[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@]([H])(CC[C@]4(C)[C@@]3([H])C[C@@]([H])(O)[C@]12C)O[C@@]1([H])C[C@]([H])(O)[C@]([H])(O[C@@]2([H])C[C@]([H])(O)[C@]([H])(O[C@@]3([H])C[C@]([H])(OC(C)=O)[C@]([H])(O[C@]4([H])O[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]4([H])O)[C@@]([H])(C)O3)[C@@]([H])(C)O2)[C@@]([H])(C)O1)C1=CC(=O)OC1Targets
What you can answer from here — as of August 27, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Lanatoside C, and which of those have an active Phase 3 trial?